Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation
Carlos Fernandez-Patron1, Dickson Leung2
1Department of Biochemistry, Cardiovascular Research Group and Mazankowski Alberta Heart Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
We review select aspects of the biology of matrix metalloproteinases (MMPs) with a focus on the modulation of inflammatory responses by MMP-2. MMP-2 is a zinc- and calcium-dependent endoprotease with substrates including extracellular matrix proteins, vasoactive peptides and chemokines. Humans and mice with MMP-2 deficiency exhibit a predominantly inflammatory phenotype. Recent research shows that MMP-2 deficient mice display elevated activity of a secreted phospholipase A2 in the heart. Additionally, MMP-2 deficient mice exhibit abnormally high prostaglandin E2 levels in various organs (i.e., the heart, brain and liver), signs of inflammation and exacerbated lipopolysaccharide-induced fever. We briefly review the biology of sPLA2 enzymes to propose the existence of a heart-centric MMP-2/sPLA2 axis of systemic inflammation. Moreover, we postulate that PLA2 activation is induced by chemokines, whose ability to signal inflammation is regulated in a tissue-specific fashion by MMPs. Thus, genetic and pharmacologically induced MMP-deficiencies can be expected to perturb PLA2-mediated inflammatory mechanisms.
Insights
Matrix metalloproteinase-2 (MMP-2) deficiency causes inflammation by affecting secreted phospholipase A2 (sPLA2) activity. This suggests a heart-centric MMP-2/sPLA2 axis in systemic inflammation.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling.
- MMP-2, a specific MMP, plays a role in regulating inflammatory responses.
- MMP-2 deficiency is associated with inflammatory phenotypes in humans and mice.
Purpose of the Study:
- To explore the role of MMP-2 in modulating inflammatory responses.
- To investigate the link between MMP-2 deficiency, secreted phospholipase A2 (sPLA2), and systemic inflammation.
- To propose a novel MMP-2/sPLA2 axis in the heart that influences systemic inflammation.
Main Methods:
- Review of existing literature on MMP biology and inflammatory pathways.
- Analysis of phenotypes in MMP-2 deficient mice, including elevated sPLA2 activity and prostaglandin E2 levels.
- Examination of inflammatory markers and responses to lipopolysaccharide challenge.
Main Results:
- MMP-2 deficient mice exhibit increased cardiac sPLA2 activity and elevated prostaglandin E2 levels in multiple organs.
- These mice show signs of inflammation and exacerbated fever responses.
- MMP-2 deficiency appears to dysregulate sPLA2-mediated inflammatory mechanisms.
Conclusions:
- A heart-centric MMP-2/sPLA2 axis is proposed as a key regulator of systemic inflammation.
- Chemokines may activate PLA2, with MMPs controlling this signaling in a tissue-specific manner.
- MMP deficiencies are likely to disrupt PLA2-mediated inflammatory processes, highlighting MMP-2's crucial role.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
IP3/DAG Signaling Pathway
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular


